Canada· CA-DIN-00707600

TRIQUILAR 21

A levonorgestrel and ethinylestradiol product containing ethinyl estradiol + levonorgestrel, registered in Canada by BAYER INC. The same ATC class is registered in 8 of our 19 countries.

ATC G03AB03

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTRIQUILAR 21ATCG03AB03REGISTER NO.CA-DIN-00707600PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Levonorgestrel and ethinylestradiol is registered in 8 of 19 countries.

Countries holding a registration under ATC G03AB03 (levonorgestrel and ethinylestradiol), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 4 of them publish a price we can compare per daily dose

Levonorgestrel and ethinylestradiol · ATC G03AB03

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
ETHINYL ESTRADIOL + LEVONORGESTREL
Manufacturer
BAYER INC
Country
Canada (CA)
ATC code
G03AB03
ATC class
Levonorgestrel and ethinylestradiol
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for levonorgestrel and ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levonorgestrel and ethinylestradiol · interactions on record

25 records

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Levonorgestrel and ethinylestradiol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levonorgestrel and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Erlidona, Ethinylestradiol/Levonorgestrel Nextpharma
  • Belgium · Eleonor 20, Lavinia
  • Bulgaria · Три-Регол
  • Czechia · Ebelya, Minisiston
  • Germany · Asumate 20, Asumate 30
  • Denmark · Anastrella, Femicept
  • Spain · Aileva, Anaomi
  • France · Adepal, Asterluna
  • United Kingdom (Northern Ireland) · Ambelina, Elevin
  • Croatia · Adexa
  • Hungary · Rigevidon, Seasonique
  • Ireland · Leonore, Levonorgestrel/ Ethinylestradiol Renata Pharmaceuticals (Ireland)
  • Iceland · Levoethin, Melleva
  • Italy · Egogyn, Lasca
  • Lithuania · Rigevidon, Tri - Regol
  • Luxembourg · Levorichter 30, Lowette
  • Latvia · Rigevidon
  • Netherlands · Ethinylestradiol/Levonorgestrel Ceres Pharma, Ethinylestradiol/Levonorgestrel Focus
  • Norway · Melleva, Microgynon
  • Poland · Levomine, Levomine Mini
  • Portugal · Effilevo, Etinilestradiol + Levonorgestrel Generis
  • Romania · Microgynon, Seasonique
  • Sweden · Anastrella, Leverette 21
  • Slovenia · Stediril-M
  • Slovakia · Ebelya, Seasonique

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd5750da-42b0-4f59-baec-9949137598c2
GET /v1/drugs/dd5750da-42b0-4f59-baec-9949137598c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00707600",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G03AB03",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "8124",
  "strengths": [
    "40 MCG",
    "30 MCG",
    "125 MCG",
    "50 MCG",
    "75 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "ETHINYL ESTRADIOL",
    "LEVONORGESTREL"
  ],
  "product_categorization": null
}

See everything about levonorgestrel and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.